Drug Development

European Commission approval for Dzuveo

July 1, 2018 Pharma News HQ 0

AcelRx’ Dzuveo has won approval in the European Union for the management of acute moderate to severe pain in medically monitored settings.Dzuveo is a sublingual tablet formulation of the opioid analgesic sufentanil, designed to address […]

Drug Development

FDA approves Pierre Fabre/Array Biotech melanoma combo

July 1, 2018 Pharma News HQ 0

US regulators have issued a green light for Pierre Fabre and Array Biotech’s encorafenib/binimetinib combination therapy for advanced BRAF-mutant melanoma.More specifically, the approval allows physicians to prescribe the combination to patients with unresectable or metastatic […]